The Center for Individualized Medicine determined that collaborating with Complete Genomics could supplement the services available to its community of medical researchers. The center will send genetic material to Complete Genomics for sequencing and analysis, while continuing to operate and invest in its own Medical Genome Facility. Financial details of the agreement were not disclosed.
"It is exciting to see a world-renowned healthcare organization like Mayo Clinic take the next step toward bringing high-quality whole genome sequencing data into the clinic. They clearly recognize its potential to personalize treatment options and improve the future quality of patient care," said Leroy Hood, M.D., Ph.D., member of Complete Genomics' scientific advisory board and president of the Institute for Systems Biology.
Projects will be coordinated with the Center of Individualized Medicine's Medical Genome Facility and will help expedite Mayo Clinic's translational genomics-based programs. Through these initiatives, Mayo Clinic will develop best practices for using genetic information to guide patient care.
